aspirin has been researched along with exudates in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Malik, AS | 1 |
| Ahmad, WA; Ramesh, SV; Zambahari, R | 1 |
| Chan, FK; Goh, KL; Mahadeva, S; Menon, J; Ng, WK; Tan, HJ; Zainal Abidin, I | 1 |
| Bujang, AM; Fong, AY; Hwang, SS; Lai, LY; Mejin, M; Ong, TK; Tiong, LL; Tiong, WN | 1 |
| Hedger, NA; Veettil, RP; Woolley, AK | 1 |
| Badve, SV; Cass, A; Hawley, CM; Hooi, SL; Irish, AB; Johnson, DW; Kerr, PG; Mori, TA; Ong, ML; Pascoe, EM; Paul-Brent, PA; Polkinghorne, KR; Scaria, A; Viecelli, AK | 1 |
| Avezum, A; Chifamba, J; Chow, C; Dagenais, G; Diaz, R; Gafni, A; Gupta, R; Ismail, N; Kazmi, K; Kelishadi, R; Khatib, R; Kruger, A; Kumar, R; Lanas, F; Lear, SA; Lopez-Jaramillo, P; McKee, M; Mohan, V; Monsef, N; Mony, P; Puoane, T; Rahman, O; Rangarajan, S; Rosengren, A; Shannon, H; Szuba, A; Temizhan, A; Teo, K; Vijayakumar, K; Wei, L; Yusoff, K; Yusuf, S | 1 |
| Hadi, MF; Hafidz, MI; Ismail, MD; Venkatason, P; Wan Ahmad, WA; Zubairi, YZ; Zuhdi, ASM | 1 |
| Ali, A; Azidin, AH; Cheah, CS; Ismail, NAS; Khoo, MS; Lee Wei Li, W; Suhaini, SA | 1 |
1 trial(s) available for aspirin and exudates
| Article | Year |
|---|---|
Baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study.
Topics: Adult; Aged; Arteriovenous Shunt, Surgical; Aspirin; Australia; Comorbidity; Docosahexaenoic Acids; Double-Blind Method; Drug Combinations; Eicosapentaenoic Acid; Female; Fibrinolytic Agents; Graft Occlusion, Vascular; Humans; Malaysia; Male; Middle Aged; New Zealand; Prevalence; Renal Dialysis; Renal Insufficiency, Chronic; Risk Factors; Severity of Illness Index; Thrombosis; Time Factors; Treatment Outcome; United Kingdom; Vascular Patency | 2016 |
8 other study(ies) available for aspirin and exudates
| Article | Year |
|---|---|
Kawasaki disease in Malaysia.
Topics: Anti-Bacterial Agents; Aspirin; Cardiovascular Diseases; Child; Child, Preschool; Drug Therapy, Combination; Echocardiography; Female; Hospitalization; Humans; Infant; Malaysia; Male; Mucocutaneous Lymph Node Syndrome; Skin Diseases | 1996 |
Malaysia-ACute CORonary syndromes Descriptive study (ACCORD): evaluation of compliance with existing guidelines in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Adult; Aspirin; Clopidogrel; Drug Therapy, Combination; Female; Guideline Adherence; Humans; Malaysia; Male; Medication Adherence; Middle Aged; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Prospective Studies; Risk Factors; Ticlopidine | 2011 |
Statements of the Malaysian Society of Gastroenterology & Hepatology and the National Heart Association of Malaysia task force 2012 working party on the use of antiplatelet therapy and proton pump inhibitors in the prevention of gastrointestinal bleeding.
Topics: Aspirin; Cardiovascular Diseases; Clopidogrel; Drug Interactions; Gastrointestinal Hemorrhage; Humans; Malaysia; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Ticlopidine | 2013 |
CYP2C19 genotypes and their impact on clopidogrel responsiveness in percutaneous coronary intervention.
Topics: Adult; Aged; Alleles; Aryl Hydrocarbon Hydroxylases; Asian People; Aspirin; Clopidogrel; Cytochrome P-450 CYP2C19; Female; Follow-Up Studies; Genotype; Humans; Malaysia; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Prevalence; Ticlopidine; Treatment Outcome | 2013 |
Problem based review: The patient with a pyrexia of unknown origin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Infective Agents; Anti-Inflammatory Agents; Aorta; Aortography; Arthralgia; Aspirin; Diagnosis, Differential; Female; Fever of Unknown Origin; Headache; Humans; Lansoprazole; Malaysia; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prednisolone; Singapore; Takayasu Arteritis; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Argentina; Aspirin; Bangladesh; Brazil; Canada; Cardiovascular Agents; Cardiovascular Diseases; Chile; China; Colombia; Developed Countries; Developing Countries; Drug Costs; Family Characteristics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Income; India; Iran; Malaysia; Pakistan; Pharmacies; Platelet Aggregation Inhibitors; Poland; Rural Population; Secondary Prevention; South Africa; Sweden; Turkey; United Arab Emirates; Urban Population; Zimbabwe | 2016 |
In-hospital mortality of cardiogenic shock complicating ST-elevation myocardial infarction in Malaysia: a retrospective analysis of the Malaysian National Cardiovascular Database (NCVD) registry.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Databases, Factual; Female; Hospital Mortality; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Logistic Models; Malaysia; Male; Middle Aged; Percutaneous Coronary Intervention; Registries; Retrospective Studies; Risk Factors; Shock, Cardiogenic; ST Elevation Myocardial Infarction; Time Factors | 2019 |
Kawasaki Disease with Hepatobiliary Manifestations.
Topics: Aspirin; Diagnosis, Differential; Humans; Immunoglobulins, Intravenous; Infant; Malaysia; Mucocutaneous Lymph Node Syndrome; Retrospective Studies | 2022 |